- ISIN
- US74112D1019
- CUSIP
- 74112D101
- Sector
- Healthcare
- Industry
- Medical Distribution
- IPO Date
- Feb 10, 2005
Highlights
- Market Cap
- $2.17B
- Enterprise Value
- $2.16B
- EPS (TTM)
- $3.91
- PE Ratio
- 11.64
- PEG Ratio
- 2.19
- Total Revenue (TTM)
- $1.09B
- Gross Profit (TTM)
- $595.58M
- EBITDA (TTM)
- $328.19M
- Year Range
- $42.62 - $84.70
- Target Price
- $66.00
- ROA (TTM)
- 5.45%
- ROE (TTM)
- 10.08%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PBH Performance Chart
Prestige Consumer Healthcare Inc. (PBH) is down 26.3% since the beginning of the year. At $45 per share, PBH is trading 46.3% below its 52-week high of $85. Investors who bought $1,000 worth of PBH shares 5 years ago would now be looking at an investment worth $871.
Loading charts...
Returns By Period
Prestige Consumer Healthcare Inc. (PBH) has returned -26.31% so far this year and -45.52% over the past 12 months. Over the last ten years, PBH has returned -1.55% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Prestige Consumer Healthcare Inc.
- 1D
- -3.21%
- 1M
- -5.29%
- YTD
- -26.31%
- 6M
- -27.47%
- 1Y
- -45.52%
- 3Y*
- -7.38%
- 5Y*
- -2.72%
- 10Y*
- -1.55%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PBH Monthly Returns History
Based on dividend-adjusted daily data since Feb 10, 2005, PBH's average daily return is +0.05%, while the average monthly return is +0.88%. At this rate, an investment would double in approximately 6.6 years.
Historically, 53% of months were positive and 47% were negative. The best month was Dec 2008 with a return of +34.9%, while the worst month was Jul 2005 at -42.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.
On a daily basis, PBH closed higher 51% of trading days. The best single day was May 10, 2018 with a return of +23.7%, while the worst single day was Jul 28, 2005 at -40.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.51% | 7.49% | -14.47% | -4.98% | -15.61% | -4.36% | -26.31% | ||||||
| 2025 | -1.69% | 10.39% | 1.44% | -5.51% | 5.47% | -6.79% | -7.39% | -7.99% | -8.29% | -2.88% | -1.73% | 3.59% | -21.00% |
| 2024 | 0.52% | 13.06% | 4.28% | -1.10% | -10.38% | 7.06% | 2.85% | 5.41% | -3.40% | 2.29% | 14.94% | -7.88% | 27.56% |
| 2023 | 5.05% | -8.38% | 3.95% | -1.76% | -6.99% | 3.84% | 9.73% | -10.55% | -1.95% | 3.79% | -3.39% | 6.75% | -2.20% |
| 2022 | -6.92% | 5.46% | -11.07% | 3.25% | 2.12% | 5.34% | 2.57% | -16.13% | -1.48% | 9.33% | 12.81% | 1.85% | 3.22% |
| 2021 | 14.71% | 4.28% | 5.68% | -1.18% | 14.49% | 4.47% | 0.86% | 9.21% | -2.23% | 6.91% | -6.73% | 8.40% | 73.93% |
Benchmark Metrics
Prestige Consumer Healthcare Inc. has an annualized alpha of 2.83%, beta of 0.86, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since February 10, 2005.
- This stock participated in 105.88% of S&P 500 Index downside but only 86.02% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 2.83%
- Beta
- 0.86
- R²
- 0.19
- Upside Capture
- 86.02%
- Downside Capture
- 105.88%
Return for Risk
Risk / Return Rank
PBH ranks 2 for risk / return — in the bottom 2% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Prestige Consumer Healthcare Inc. (PBH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PBH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.55 | ||
| Sortino ratioReturn per unit of downside risk | -4.95 | ||
| Omega ratioGain probability vs. loss probability | 0.71 | 1.37 | -0.66 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 2.78 | -3.77 |
| Martin ratioReturn relative to average drawdown | -1.65 | 12.44 | -14.09 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Prestige Consumer Healthcare Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Prestige Consumer Healthcare Inc. was 80.60%, occurring on Mar 11, 2009. Recovery took 935 trading sessions.
The current Prestige Consumer Healthcare Inc. drawdown is 48.97%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -80.60%Mar 2009 | 3y 8mo | 3y 8mo | 7y 4moJul 2005 - Nov 2012 |
2019 bear market2019 | -53.75%Mar 2019 | 2y 9d | 2y 4mo | 4y 5moMar 2017 - Aug 2021 |
2026 bear market2026 | -49.00%Jun 2026 | 1y 15d | — | 1y 1moMay 2025 - now |
2014 bear market2014 | -27.12%Feb 2014 | 1mo 11d | 9mo 3d | 10mo 14dDec 2013 - Nov 2014 |
Bear market2022 | -23.03%Sep 2022 | 10mo 19d | 2mo 6d | 1y 20dNov 2021 - Dec 2022 |
Drawdown Indicators
| PBH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.60% | -56.78% | -23.82% |
Max Drawdown (1Y)Largest decline over 1 year | -46.33% | -9.10% | -37.23% |
Max Drawdown (3Y)Largest decline over 3 years | -49.00% | -18.90% | -30.10% |
Max Drawdown (5Y)Largest decline over 5 years | -49.00% | -25.43% | -23.57% |
Max Drawdown (10Y)Largest decline over 10 years | -53.75% | -33.92% | -19.83% |
Current DrawdownCurrent decline from peak | -48.97% | -1.80% | -47.17% |
Average DrawdownAverage peak-to-trough decline | -28.04% | -10.71% | -17.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.67% | 2.03% | +25.64% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Prestige Consumer Healthcare Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Prestige Consumer Healthcare Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PBH, comparing it with other companies in the Medical Distribution industry. Currently, PBH has a P/E ratio of 11.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PBH compared to other companies in the Medical Distribution industry. PBH currently has a PEG ratio of 2.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PBH relative to other companies in the Medical Distribution industry. Currently, PBH has a P/S ratio of 2.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PBH in comparison with other companies in the Medical Distribution industry. Currently, PBH has a P/B value of 1.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PBH
Add Prestige Consumer Healthcare Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PBH